International Society

INCOG BioPharma Services Continues Positive Momentum

Retrieved on: 
Dienstag, April 30, 2024
FDA, International Society, Food, CDMO, Patient, Commerce, Facility, GMP, ISPE, Growth, Medication

 FISHERS, Ind, April 30, 2024 /PRNewswire/ -- INCOG BioPharma Services proudly announces that its sterile injectable manufacturing facility has received approval from the U.S. Food and Drug Administration (FDA) to produce a commercially approved drug product. The regulatory approval for its customer signifies a significant milestone for INCOG, as it positions itself as an emerging leader in the biopharmaceutical contract manufacturing industry.

Key Points: 
  • FISHERS, Ind, April 30, 2024 /PRNewswire/ -- INCOG BioPharma Services proudly announces that its sterile injectable manufacturing facility has received approval from the U.S. Food and Drug Administration (FDA) to produce a commercially approved drug product.
  • The FDA approval comes after a rigorous inspection of INCOG's facility and quality systems, during which INCOG demonstrated compliance with FDA requirements for aseptic manufacturing.
  • "We are thrilled to receive our initial FDA approval," said JR Humbert, VP of Quality for INCOG.
  • "These accolades reinforce our dedication to delivering high-quality products and creating a positive workplace culture."

Questex’s IHIF EMEA 2024: The Meeting Place of Hospitality Innovators and Game-Changers

Retrieved on: 
Mittwoch, April 10, 2024
Diamond, CBRE, Axa, Starwood Capital Group, International Society, Ecosystem, QIA, Choice Hotels, News, ISHC, InterContinental, Appetite, Marriott International, Young, Cushman & Wakefield, JLL, Radisson Hotel Group, Wyndham Hotels & Resorts, NH Hotel Group, Union Investment, Organization

The investor community attendance is record-breaking this year, with 40% of the investor audience attending IHIF EMEA for the first time.

Key Points: 
  • The investor community attendance is record-breaking this year, with 40% of the investor audience attending IHIF EMEA for the first time.
  • Expect unparalleled opportunity for deal-making, networking, and garnering invaluable insights to propel the hospitality investment industry forward,” said Julie Rey-Gore, Content Director, IHIF EMEA.
  • The highly anticipated HAMA Awards will be presented by IHIF EMEA and the Hospitality Asset Managers Association (HAMA) Europe and is co-sponsored by Questex Hospitality and HotStats.
  • For more information about IHIF EMEA 2024 and to register for the event, visit IHIF EMEA website .

Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions

Retrieved on: 
Dienstag, April 23, 2024
Medical Devices, Health, Neurology, Health Technology, Clinical Trials, Radiology, FDA, Brain, International Society, Amyloid-related imaging abnormalities, ARIA, Abstract, Conference, CARE, Patient, Magnetic resonance, Observational study, Physician, Multiple sclerosis, Hyperfine structure, Biomarker, Medical imaging

These seventeen abstracts span a wide variety of use cases, including two that highlight the utility of brain images acquired with the ultra-low-field Swoop® Portable MR Imaging® system to aid physicians screening for various biomarkers and monitoring disease progression unique to neurodegenerative diseases, including Alzheimer’s and multiple sclerosis (MS).

Key Points: 
  • These seventeen abstracts span a wide variety of use cases, including two that highlight the utility of brain images acquired with the ultra-low-field Swoop® Portable MR Imaging® system to aid physicians screening for various biomarkers and monitoring disease progression unique to neurodegenerative diseases, including Alzheimer’s and multiple sclerosis (MS).
  • Conference attendees can learn more during these select presentations:
    “These abstracts are very encouraging.
  • Earlier this month, the company announced that the first patients have been scanned in the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) study.
  • For more information about the Swoop® Portable MR Imaging® system, please visit hyperfine.io.

Children’s Hospital Los Angeles Researcher Reviews the Current State of Retinoblastoma Research in the New England Journal of Medicine

Retrieved on: 
Freitag, April 19, 2024
Children, Health, Publishing, Optical, Oncology, Communications, Research, Hospitals, Genetics, Consumer, Science, International Society, Cancer, Cell, NIH, CHLA, Death, MD, Doctor of Philosophy, RB1, Disease, Retina, Patient, Eye, Neoplasm, Biopsy, Multimedia, Vaccine

David Cobrinik, MD, PhD , has contributed to many of these advances in his work at the Vision Center at Children’s Hospital Los Angeles.

Key Points: 
  • David Cobrinik, MD, PhD , has contributed to many of these advances in his work at the Vision Center at Children’s Hospital Los Angeles.
  • Recently, Dr. Cobrinik was invited to write an article about the current understanding of the development of retinoblastoma.
  • View the full release here: https://www.businesswire.com/news/home/20240419652243/en/
    Children's Hospital Los Angeles has been at the forefront of retinoblastoma research for decades.
  • Dr. David Cobrinik was invited to review the current state of retinoblastoma research in the New England Journal of Medicine.

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging

Retrieved on: 
Donnerstag, April 18, 2024
Other Health, Consumer, Medical Devices, Technology, Hospitals, Artificial Intelligence, Surgery, Cardiology, Women, Biotechnology, Medical Supplies, Health, International Society, GE HealthCare, Pregnancy, Woman, AI, Endometriosis, Artificial intelligence, Workflow, Pelvic floor, Motion, Female, Automation, Patient, Diagnosis, Anomaly scan, Medical imaging

GE HealthCare (Nasdaq: GEHC) today announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) today announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health.
  • These latest systems combine high-performance hardware with flexible scalable software to help increase clinicians’ confidence in their diagnostic and treatment determinations.
  • "We've seen huge advancements in ultrasound technology, including the use of AI, resulting in a new era of ultrasound scanning.
  • For more information on the Voluson Signature 20 and 18 devices, visit https://www.gehealthcare.com/products/ultrasound/voluson/voluson-signatu... and https://www.gehealthcare.com/products/ultrasound/voluson/voluson-signatu... .

Global Dermal Fillers Industry Research 2023-2035: Market Set to Expand; Hyaluronic Acid Dominates with Innovation in Minimally Invasive Aesthetics - ResearchAndMarkets.com

Retrieved on: 
Freitag, April 12, 2024
Cosmetics, Retail, Pharmaceutical, Health, Market, Aesthetic Plastic Surgery, Lactic acid, International Society, Hyaluronic acid, Social media, Skin, Injectable filler, Filler (linguistics), Medical tourism, Anesthesia, Patient, Gender, Face, Ageing, Lip, Bruise, Growth

Dermal fillers are a type of injectable treatment which consists of hyaluronic acid in the form of a gel-like substance, also known as facial fillers.

Key Points: 
  • Dermal fillers are a type of injectable treatment which consists of hyaluronic acid in the form of a gel-like substance, also known as facial fillers.
  • Dermal fillers often comprise hyaluronic acid, lactic acid, calcium hydroxyapatite, polymethyl methacrylates and polyacrylamide gels.
  • Of these, 86% of the procedures were done using hyaluronic fillers, with rest accounting for non hyaluronic acid fillers.
  • The dermal fillers market report presents an in-depth analysis of the various companies that are engaged in the global dermal fillers industry, across different segments, as defined below:

Nodexus Adds Flow Cytometry Leaders to Scientific Advisory Board

Retrieved on: 
Mittwoch, April 10, 2024
Oncology, Health, Health Technology, Research, Science, Pharmaceutical, Biotechnology, Breast cancer, Science Publishing Group, Immortalised cell line, University, International Society, ISAC, Jonni, SAB, CRISPR, Cell biology, Hospital, Seminal vesicles, Medical laboratory, Doctor of Philosophy, Pathology, Protein engineering, Therapy, New York Blood Center, Chairperson, Synthetic biology, Cardiovascular disease, Malignancy, Assistant, Inc., NX, HIV, Biomarker, Associate, SICS, AAPS, Flow cytometry

Nodexus Inc., a leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that three leading experts in cytometry sciences, pathology, and cancer biology have joined its Scientific Advisory Board (SAB).

Key Points: 
  • Nodexus Inc., a leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that three leading experts in cytometry sciences, pathology, and cancer biology have joined its Scientific Advisory Board (SAB).
  • The Nodexus SAB is chaired by Professor Jonni Moore, PhD, one of the world’s leading experts in flow cytometry, laboratory medicine, and cellular immunology.
  • He is a founding member of the Southern California Flow Cytometry Association (SoCal Flow) and the American Association of Pharmaceutical Scientists (AAPS) PharmaFlow Working Group.
  • “I’m extremely pleased to serve as the Chairperson of Nodexus’ Scientific Advisory Board,” said Dr. Moore.

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on: 
Freitag, April 26, 2024
Humidity, International Society, MMM, Stroke, Embolism, Atrial fibrillation, ZERO, Risk, Blood pressure, Research, Hypertension, ECG, OMRON, Incidence, Patient, Business, Cardiovascular disease, Death, Temperature, PLOS, Heart failure, Pharmaceutical industry

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points: 
  • MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
  • May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
  • Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
  • Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on: 
Freitag, April 26, 2024
Humidity, International Society, MMM, Stroke, Embolism, Atrial fibrillation, ZERO, Risk, Blood pressure, Research, Hypertension, ECG, OMRON, Incidence, Patient, Business, Cardiovascular disease, Death, Temperature, PLOS, Heart failure, Pharmaceutical industry

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points: 
  • MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
  • May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
  • Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
  • Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

ISA Celebrates Third Annual International Automation Professionals Day

Retrieved on: 
Donnerstag, April 25, 2024
International Society, Social media, Mentorship, Book, Heart, Engineering, Automation, Swag, ISA, Student, Entertainment

DURHAM, N.C., April 25, 2024 /PRNewswire/ -- The International Society of Automation (ISA) – the leading professional society for automation – will celebrate its third annual International Automation Professionals Day on 28 April 2024.

Key Points: 
  • DURHAM, N.C., April 25, 2024 /PRNewswire/ -- The International Society of Automation (ISA) – the leading professional society for automation – will celebrate its third annual International Automation Professionals Day on 28 April 2024.
  • "28 April marks ISA's founding and celebrates automation professionals around the world," said Claire Fallon, ISA CEO.
  • International Automation Professionals Day is celebrated each year on 28 April in commemoration of ISA's founding on that date in 1945.
  • "I encourage all of us to come together and celebrate each other during International Automation Professionals Day," he said.